| Daniel J Kanefield, PHARM D | |
|
2305 Theatre Dr, Paso Robles, CA 93446-9604 | |
| (805) 227-4304 | |
| Not Available |
| Full Name | Daniel J Kanefield |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2305 Theatre Dr, Paso Robles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689951378 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 44498 (California) | Primary |
| 183500000X | Pharmacist | 15132 (Arizona) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Daniel J Kanefield, PHARM D Po Box 855, Templeton, CA 93465-0855 Ph: () - | Daniel J Kanefield, PHARM D 2305 Theatre Dr, Paso Robles, CA 93446-9604 Ph: (805) 227-4304 |
News Archive
Writing the latest pages of an anthropological mystery, scientists propose in this month's Archives of Neurology that it is highly possible that Auguste Deter, the first identified Alzheimer disease patient, carried the N141I presenilin-2 mutation—the same one as in present-day U.S. families descended from German emigrants who settled near the river Volga in Russia.
The U.S. Food and Drug Administration today approved Jevtana (cabazitaxel), a chemotherapy drug used in combination with the steroid prednisone to treat men with prostate cancer. Jevtana is the first treatment for advanced, hormone-refractory, prostate cancer that has worsened during or after treatment with docetaxel, a commonly used drug for advanced prostate cancer.
In an online-only, open access special issue of the American Journal of Public Health, researchers investigate issues of health equity, quality and disparities within the Veterans Affairs health care system.
Using two biocompatible parts, University at Buffalo researchers and their colleagues have designed a nanoparticle that can be detected by six medical imaging techniques.
Researchers have reported the first case of COVID-19 triggering a rare occurrence of potentially severe blood clots forming in the arms.
› Verified 7 days ago
Mrs. Maria C De Nysschen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2424 Spring St, Paso Robles, CA 93446 Phone: 805-239-3208 Fax: 805-239-1878 | |
Abigail Victoria Joy, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 187 Niblick Rd, Paso Robles, CA 93446 Phone: 805-238-2947 | |
Sarah Elizabeth Stafford, BPHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 187 Niblick Rd, Paso Robles, CA 93446 Phone: 805-238-2947 Fax: 805-238-3251 | |
Ms. Minakshi Gurbhele, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 187 Niblick Rd, Paso Robles, CA 93446 Phone: 805-238-2947 | |
David Bircher, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 187 Niblick Rd, Paso Robles, CA 93446 Phone: 805-238-2947 Fax: 805-238-3251 | |
Kellie Jones, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2424 Spring St, Paso Robles, CA 93446 Phone: 805-239-3208 Fax: 805-239-1878 | |
Stuart Wensil, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 189 Niblick Rd, Paso Robles, CA 93446 Phone: 805-237-1803 Fax: 805-237-8768 |